RichardLeoWahlMD

Elizabeth E. Mallinckrodt Professor of Radiology. Director: Mallinckrodt Institute of Radiology. Washington University School of Medicine. St. Louis, MO.

Join to view full profile

Dr. Wahl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wahl's full profile

Already have an account?

Office
510 S Kingshighway Blvd
Dept
Saint Louis, MO 63110
Phone+1 314-362-7200

Fax+1 314-747-4189

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Allergy and Immunology, 1981 - 1983
Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 1979 - 1983
University of California (San Diego) Medical CenterInternship, Internal Medicine, 1978 - 1979
Washington University in St. Louis School of MedicineClass of 1978

Certifications & Licensure

MI State Medical License 1983 - 2026
MO State Medical License 2014 - 2026
MD State Medical License 2000 - 2017
IL State Medical License 1982 - 1984
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology
American Board of Radiology Nuclear Radiology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:Arizona State Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2006-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Elected Member The American Society for Clinical Investigation, 1989
Join now to see all

Clinical Trials

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma Start of enrollment: 2007 Jun 01
Completed
Phase 1, Phase 2
FBnTP Imaging of Breast Cancer Start of enrollment: 2015 Mar 12
Terminated
Phase 1
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR Start of enrollment: 2016 Mar 01
Completed
Phase 1
18F-FLT PET Imaging in Patients With Advanced Melanoma Start of enrollment: 2016 Oct 10
Terminated
Phase 1
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT Start of enrollment: 2021 Apr 22
WITHDRAWN
PHASE2
Gated and Non-Gated Dynamic PET/CT Imaging Start of enrollment: 2020 May 29
Terminated
Not Applicable
Roles: Principal Investigator, Contact
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
RECRUITING
PHASE3
Roles: Contact
A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer Start of enrollment: 2021 Sep 14
Terminated
Phase 1, Phase 2
Roles: Contact
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients with Advanced Solid Tumours Start of enrollment: 2024 Jul 31
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

A compositeF-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026).
Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter, Jennifer M Kachergus, Yaohua Ma
Breast. 2025-03-01
Quantitative and Visual Benefits of Data-Driven Motion Correction on Oncologic PET/CT: A Prospective Cross-sectional Study.
Semra Ince, M Allan Thomas, Malak Itani, Christopher Swingle, Richard Laforest
Academic Radiology. 2025-01-24
14 citations
Radiotherapy and theranostics: a Lancet Oncology Commission.
May Abdel-Wahab, Francesco Giammarile, Mauro Carrara, Diana Paez, Hedvig Hricak
The Lancet. Oncology. 2024-11-01

Journal Articles

Dynamic Whole-Body PET Imaging: Principles, Potentials and Applications
Richard Wahl, MD, European Journal of Nuclear Medicine and Molecular Imaging
Original Research Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach
Thomas H Schindler, Richard L Wahl, Martin G Pomper, Dean F Wong, Kimberley Steele, ScienceDirect

Press Mentions

IAEA Touts Radionuclide Development ActivitiesMarch 18th, 2025
Actineer Appoints New President, CEOJanuary 16th, 2025
Calif. Exemption Changes Nuclear Medicine Tech Scope of PracticeJanuary 10th, 2025
Join now to see all

Grant Support

Precision next-generation radioimmunotherapies to Cure Non-Hodgkin LymphomaWASHINGTON UNIVERSITY2024–2029
Training OPportunites in Translational Imaging Education and Research (TOP-TIER)WASHINGTON UNIVERSITY2017–2027

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/richard-wahl